These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33209635)

  • 1. A pathological complete response to neoadjuvant chemotherapy and immunotherapy in a non-small cell lung cancer patient.
    Gao P; Chen H; Zeng T; Wu W; Xu G; Xu C; Zheng B; Zhu Y; Zheng W; Chen C
    Transl Lung Cancer Res; 2020 Oct; 9(5):2157-2160. PubMed ID: 33209635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for immunotherapy when neoadjuvant chemoradiotherapy achieves pathologic complete response in stage IIIB non-small cell lung cancer: a case report.
    Lv C; Zhao L; Zhu Y; Wang P; Sun Z
    Ann Palliat Med; 2021 Apr; 10(4):4965-4969. PubMed ID: 33966430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of video-assisted thoracic surgery lobectomy after neoadjuvant chemotherapy plus toripalimab in a patient with locally advanced non-small cell lung cancer: a case report.
    Li W; Zhai C; Che J; Wang W; Liu B
    J Cardiothorac Surg; 2022 Jan; 17(1):10. PubMed ID: 35034650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative pathological complete response in a patient with PD‑L1‑negative stage IIIB lung squamous cell carcinoma following neoadjuvant tislelizumab treatment combined with chemotherapy: A case report and literature review.
    Cui G; Qu D; Bai Y; Sun X; Li Y; Yang Y
    Oncol Lett; 2023 Sep; 26(3):388. PubMed ID: 37559583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-port video-assisted thoracoscopic sleeve lobectomy after neoadjuvant immunochemotherapy: a case report.
    Chen H; Zhang J; Rossi A; Divisi D; Chen C; Zheng B
    Transl Lung Cancer Res; 2024 Feb; 13(2):423-433. PubMed ID: 38496704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy.
    Yang ZR; Liu MN; Yu JH; Yang YH; Chen TX; Han YC; Zhu L; Zhao JK; Fu XL; Cai XW
    Transl Lung Cancer Res; 2020 Oct; 9(5):2059-2073. PubMed ID: 33209626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review.
    Zheng Y; Zhu W; Huang X; Lin D; Lin Y
    Open Life Sci; 2021; 16(1):838-844. PubMed ID: 34514162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case report.
    Yang J; Xia H; Sun F; Zhang P; Jiang G
    Ann Transl Med; 2021 Apr; 9(8):724. PubMed ID: 33987422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy.
    Mielgo-Rubio X; Montemuiño S; Jiménez U; Luna J; Cardeña A; Mezquita L; Martín M; Couñago F
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?
    Yao Y; Tang D; Gao W; Zhang H
    Front Surg; 2022; 9():843987. PubMed ID: 35449550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery
    Jia G; Zhou S; Xu T; Huang Y; Li X
    Front Oncol; 2022; 12():954685. PubMed ID: 36185263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer.
    Shin J; Chung JH; Kim SH; Lee KS; Suh KJ; Lee JY; Kim JW; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Bang SM; Lee JS
    Cancer Res Treat; 2019 Jul; 51(3):1086-1097. PubMed ID: 30428640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy.
    Vrankar M; Stanic K
    Radiol Oncol; 2018 Feb; 52(3):281-288. PubMed ID: 30210037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 19. Unmet Clinical Need in the Management of Locally Advanced Unresectable Lung Cancer: Treatment Strategies to Improve Patient Outcomes.
    Rajappa S; Sharma S; Prasad K
    Adv Ther; 2019 Mar; 36(3):563-578. PubMed ID: 30693419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary team.
    Ma D; Xu Y; Qin Y; Li S; Li J; Jiang Y; Wang M; Xu Y; Zhao J; Chen M; Cheng W; Hu K; Liu H
    Ann Transl Med; 2022 May; 10(10):609. PubMed ID: 35722361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.